NANCY DENYES - 16 Feb 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
General Counsel
Signature
/s/ Nancy E. Denyes
Issuer symbol
LIFE
Transactions as of
16 Feb 2023
Transactions value $
$0
Form type
4
Filing time
21 Feb 2023, 16:00:23 UTC
Previous filing
06 Feb 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Employee Stock Option (right to buy) Award $0 +84,023 $0 84,023 16 Feb 2023 Common Stock 84,023 $2.2 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.